| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nuvectis Pharma, Inc. (NVCT) has 7 insiders with recent SEC Form 4 filings, including 9 buys and 1 sell. NVCT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.68M | $73.08M | - | |
| 10% | 3.14M | $62.36M | - | |
| Other | 1.81M | $35.91M | - | |
| Other | 1.79M | $35.65M | - | |
| VP | 200.1K | $3.98M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2024 | Mosseri Marlio Charles46 | 10% Owner | Buy | 17,000 | $4.70 | $79,900.00 | +0.7% | +77.7% | +61.5% | |
| Nov 19, 2024 | Poradosu Enrique70 | Chief Science &Business Off | Buy | 2,000 | $4.99 | $9,980.00 | +0.1% | +50.6% | +16.1% | |
| Nov 15, 2024 | Bentsur Ron64 | Chairman &CEO | Buy | 20,000 | $4.92 | $98,400.00 | +0.6% | +40.4% | +21.6% | |
| Nov 7, 2024 | Carson Michael J. | Vice President, Finance | Sell | 2,755 | $8.16 | $22,478.05 | -3.0% | -14.3% | -26.4% | |
| May 14, 2024 | Bentsur Ron64 | Chairman &CEO | Buy | 1,940 | $6.74 | $13,075.60 | - | -6.9% | +36.5% | |
| May 10, 2024 | Bentsur Ron64 | Chairman &CEO | Buy | 2,000 | $6.40 | $12,800.00 | - | +6.9% | +40.5% | |
| May 10, 2024 | Poradosu Enrique70 | Chief Science &Business Off | Buy | 500 | $6.29 | $3,145.00 | - | +6.9% | +40.5% | |
| May 10, 2024 | Shemesh Shay72 | Chief Dev. &Ops. Officer | Buy | 1,113 | $6.32 | $7,034.16 | - | +6.9% | +40.5% | |
| Mar 18, 2024 | Bentsur Ron64 | Chairman &CEO | Buy | 5,000 | $10.29 | $51,450.00 | +0.2% | -34.4% | -9.7% | |
| Oct 10, 2023 | Bentsur Ron64 | Chairman &CEO | Buy | 640 | $11.08 | $7,091.20 | - | -5.7% | -43.5% |